SCHEMBL3768906

SCHEMBL3768906

Oc1ccccc1/N=C/c1ccc(-c2ccccc2Cl)o1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 8/20 0.53
▸ MAPK1 P28482 5/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ MAPT P10636 10/20 0.52
▸ ALDH1A1 P00352 5/20 0.52
▸ SMN1; SMN2 Q16637 4/20 0.52
▸ KMT2A Q03164 8/20 0.50
▸ MEN1 O00255 7/20 0.50
▸ LMNA P02545 6/20 0.50
▸ HPGD P15428 5/20 0.50
▸ GAA P10253 3/20 0.50
▸ TDP1 Q9NUW8 2/20 0.50
▸ NPSR1 Q6W5P4 4/20 0.49
▸ NPC1 O15118 3/20 0.49
▸ RAB9A P51151 3/20 0.49
▸ RCE1 Q9Y256 1/20 0.49
▸ HTT P42858 3/20 0.45
▸ POLB P06746 4/20 0.44
▸ PKM P14618 2/20 0.44
▸ GLA P06280 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3678245 1.00 KDM4E (0.53) KDM4EMAPK1HSD17B10MAPTALDH1A1
SCHEMBL3768960 0.81 MAPT (0.53) KDM4EMAPK1MAPTALDH1A1SMN1; SMN2
SCHEMBL3681086 0.81 MAPT (0.53) KDM4EMAPK1MAPTALDH1A1SMN1; SMN2
SCHEMBL3764031 0.80 NPFFR1 (0.62) KDM4EMAPK1MAPTALDH1A1SMN1; SMN2
SCHEMBL3682013 0.80 NPFFR1 (0.62) KDM4EMAPK1MAPTALDH1A1SMN1; SMN2
SCHEMBL3765182 0.77 KDM4E (0.73) KDM4EMAPK1HSD17B10MAPTALDH1A1
SCHEMBL3765183 0.77 KDM4E (0.73) KDM4EMAPK1HSD17B10MAPTALDH1A1
SCHEMBL17367500 0.73 HPGD (0.46) KDM4EMAPK1HSD17B10MAPTALDH1A1
SCHEMBL3765667 0.72 NPFFR1 (0.55) KDM4EMAPK1MAPTALDH1A1SMN1; SMN2
SCHEMBL3765671 0.72 NPFFR1 (0.55) KDM4EMAPK1MAPTALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426540-B2 Tridentate ligand compounds with imino furan units, method for manufacturing said compounds, and their use in the preparation of catalysts for the homopolymerisation and copolymerisation of ethylene and alpha-olefins TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2013-04-23 — — US claimed
US-20100311930-A1 New Tridentate Ligand Compounds with Imino Furan Units, Method for Manufacturing Said Compounds, and their use in the Preparation of Catalysts for the Homopolymerisation and Copolymerisation of Ethylene and Alpha-Olefins TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2010-12-09 — — US claimed
EP-2003125-A1 NEW TRIDENTATE LIGAND COMPOUNDS WITH IMINO FURAN UNITS, METHOD FOR MANUFACTURING SAID COMPOUNDS, AND THEIR USE IN THE PREPARATION OF CATALYSTS FOR THE HOMOPOLYMERISATION AND COPOLYMERISATION OF ETHYLENE AND ALPHA-OLEFINS TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2008-12-17 — — EP claimed
US-8426540-B2 Tridentate ligand compounds with imino furan units, method for manufacturing said compounds, and their use in the preparation of catalysts for the homopolymerisation and copolymerisation of ethylene and alpha-olefins TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2013-04-23 — — US disclosed
US-20100311930-A1 New Tridentate Ligand Compounds with Imino Furan Units, Method for Manufacturing Said Compounds, and their use in the Preparation of Catalysts for the Homopolymerisation and Copolymerisation of Ethylene and Alpha-Olefins TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2010-12-09 — — US disclosed
EP-2003125-A1 NEW TRIDENTATE LIGAND COMPOUNDS WITH IMINO FURAN UNITS, METHOD FOR MANUFACTURING SAID COMPOUNDS, AND THEIR USE IN THE PREPARATION OF CATALYSTS FOR THE HOMOPOLYMERISATION AND COPOLYMERISATION OF ETHYLENE AND ALPHA-OLEFINS TOTAL PETROCHEMICALS RESEARCH FELUY (BE) 2008-12-17 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311930-A1 New Tridentate Ligand Compounds with Imino Furan Units, Method for Manufacturing Said Compounds, and their use in the Preparation of Catalysts for the Homopolymerisation and Copolymerisation of Ethylene and Alpha-Olefins FDFT1, ETFB, ETFA KDM4E 3630/4885MAPK1 3886/4885HSD17B10 2747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback